Search Results

1 - 10 of 360 items :

  • "haemodialysis" x
Clear All

References 1 Mailloux LU, Bellucci AG, Wilkes BM, et al . Mortality in dialysis patients: Analysis of the causes of death. Am J Kidney Dis, 1991 (18):326-327. 2 Wei Q. Study on Hemodialysis Patients with Concurrent Infection. Chinese Journal of Nosocomiology, 2004,14 (5): 599 - 600. 3 Wan H. Analysis on Factors of Central Venous Catheter Infection and Status Quo of Nursing Research. Chinese Nursing Research, 2005,19 (9): 1791 - 1792. 4 Ma Y. Observation on the Nursing Effect of the Prevention of Catheter-related Infection in Hemodialysis Patients. Journal of

, et al. Catheter patency and function after catheter sheath disruption: A pilot study. Clin J Am Soc Nephrol 2007;2:1201-6. 9. Yevzlin AS. Hemodialysis catheter-associated central venous stenosis. Semin Dial 2008;21:522-7. 10. Antón-Pérez G, Pérez-Borges P, Alonso-Almán F, Vega-Díaz N. Vascular accesses in haemodialysis: A challenge to be met. Nefrologia 2012;32:103-7. 11. Chen YP. Cardiovascular disease caused by chronic kidney disease. Chin J Pract Intern Med 2010;30:108-10. 12. Wang GQ, Chen YP. Antithrombotic therapy for coronary heart disease in patients

References 1. Kidney Disease Improving Global Outcomes. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl 2012; 2: 283-35. 2. Gejyo F, Saito A, Akizawa T, et al. Japanese Society for Dialysis Therapy Guidelines for Renal Anemia in Chronic Hemodialysis Patients. Ther Apher Dial 2004; 8: 443-59. https://doi.org/10.1111/j.1774-9987.2004.00199.x 3. Kanbay M, Perazella MA, Kasapoglu B, et al. Erythropoiesis Stimulatory Agent-Resistant Anemia in Dialysis Patients: Review of Causes and Management. Blood Purif 2010; 29: 1

hemodialysis study. Kidney Int Suppl 2000; 57: S74-S81. 4. Lindsay RM, Heidenheim PA. Nesrallah G, et al. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid and sensitive to change. Clin J Am Soc Nephrol 2006; 1(5): 952-959. 5. Jaber BL, Lee Y, Collins AJ, et al. FREEDOM Study group. Effect on daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis 2010

hemodialysis access. Ultrasound Clinics 2013; 8(2): 137-146. 50. Asif A, Ravani P, Roy-Chaudhury P, et al . Vascular mapping techniques: advantages and disadvantages. J Nephrol 2007; 20(3): 299-303. 51. Van Hooland S, Donck J, Ameye F, Aerden D. Duplex ultrasonografy and haemodialysis vascular access: a practical review. Int J Nephrol Urol 2010; 2(2): 283-293. 52. Ilhan G, Esi E, Bozok S, et al . The clinical utility of vascular mapping with Doppler ultrasound prior to arteriovenous fistula construction for hemodialsis access. J Vasc Access 2013; 14(1): 83-88. 53

2007; 45 (2): 420-6. 5. Lameire N, Van Biesen W. A ‘secular’ view on vascular access in haemodialysis. Nephrol Dial Transplant 2012; 0: 1–4. 6. Cui J, Steele D, Wenger J et al. Hemodialysis arteriovenous fistula as first option not necessary in elderly patients. J Vasc Surg 2016; 63(5): 1326-32; doi: 10.1016/j.jvs.2015.11.036. 7. Tordoir JH, Bode AS, van Loon MM. Preferred strategy for hemodialysis access creation in elderly patients. Eur J Vasc Endovasc Surg 2015; 49(6): 738-43; doi: 10.1016/j.ejvs.2015.02.006. 8. Murea M, Satko S. Looking Beyond “Fistula First” in

, Hedderwick SA, Kurokawa K, Combe C, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int 2003;63:2222-9. 22. Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: Analysis of registry data. Nephrol Dial Transplant 2009;24:1598-603. 23. Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, et al. Prevalence of occult hepatitis B and hepatitis C virus

References Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis. 2000;35(4Suppl1):S117-31. doi:10.1016/S0272- 6386(00)70239-3 PMID:10766010 Causes of death. United States Renal Data System. Am J Kidney Dis. 1998;32(2 Suppl 1):S81-8. doi:10.1053/ ajkd.1998.v32.pm9713410 PMID:9713410 Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM. Cardiac calcification in adult hemodialysis patients a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002

Haemodialysis Patients and Healthy Individuals. J Clin Diagnostic Res. 2016;10(9):36-40. DOI: 10.7860/JCDR/2016/21897.8523 32. Ikewaki K. In vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease. Clin Exp Nephrol. 2014;18(2):261-264. DOI: 10.1007/s10157-013-0881-x 33. Yeo Y, Byun SW, Lee JY, Min WK, Park JS, Kim SB. Lack of association between small dense low-density lipoprotein levels and coronary artery disease in chronic hemodialysis patients. Am J Nephrol. 2009;30(3):310-314. DOI: 10.1159/000225939 34

Am Soc Nephrol. 2014 Apr 24. [Epub ahead of print] 7. Iliescu EA, Coo H, McMurray MH, et al. Quality of sleep and health-related quality of life in haemodialysis patients. Nephrol Dial Transplant. 2003;18(1):126-32. 8. Bilgic A, Akgul A, Sezer S, et al. Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr. 2007;17(6):381-8. 9. Edalat-Nejad M, Qlich-Khani M. Quality of life and sleep in hemodialy-sis patients. Saudi J Kidney Dis Transpl. 2013;24(3):514-8. 10. Turkmen K, Erdur FM, Guney I, et al. Sleep quality